DRUG

fedratinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for fedratinib

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
JAK2 poor prognosis 0.208 Mid partial evidence none

Clinical trials

33 registered trials for fedratinib

Source: ClinicalTrials.gov

← All drugs